Clinical trials
Phase 1/2 Neoplasm Metastasis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
387 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 7 |
| 2002 | 5 |
| 2003 | 2 |
| 2004 | 5 |
| 2005 | 11 |
| 2006 | 8 |
| 2007 | 3 |
| 2008 | 11 |
| 2009 | 13 |
| 2010 | 9 |
| 2011 | 8 |
| 2012 | 10 |
| 2013 | 12 |
| 2014 | 15 |
| 2015 | 8 |
| 2016 | 12 |
| 2017 | 13 |
| 2018 | 20 |
| 2019 | 19 |
| 2020 | 25 |
| 2021 | 38 |
| 2022 | 34 |
| 2023 | 29 |
| 2024 | 9 |
| 2025 | 17 |
| 2026 | 31 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 119 |
| Terminated | 84 |
| Recruiting | 84 |
| Unknown status | 40 |
| Active, not recruiting | 35 |
| Withdrawn | 15 |
| Not yet recruiting | 8 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 18 |
| M.D. Anderson Cancer Center | 13 |
| Memorial Sloan Kettering Cancer Center | 7 |
| Beijing Biotech | 6 |
| Chinese PLA General Hospital | 5 |
| NextCure, Inc. | 5 |
| AstraZeneca | 4 |
| Cell Genesys | 4 |
| Duke University | 4 |
| Incyte Biosciences International Sàrl | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasm Metastasis | 387 |
| Neoplasms | 75 |
| Carcinoma, Non-Small-Cell Lung | 66 |
| Melanoma | 63 |
| Breast Neoplasms | 60 |
| Colorectal Neoplasms | 59 |
| Pancreatic Neoplasms | 43 |
| Lung Neoplasms | 38 |
| Ovarian Neoplasms | 37 |
| Triple Negative Breast Neoplasms | 33 |
Trials
Showing 26 to 50 of 387. Each trial links to its page on Pharma Observatory.
287 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.